Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Accumulated Expenses: 2022-2023

Historic Accumulated Expenses for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $3.4 million.

  • Therapeutics' Accumulated Expenses rose 2.09% to $3.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.4 million, marking a year-over-year increase of 2.09%. This contributed to the annual value of $3.8 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Therapeutics reported Accumulated Expenses of $3.4 million as of Q3 2023, which was down 9.89% from $3.8 million recorded in Q2 2023.
  • Over the past 5 years, Therapeutics' Accumulated Expenses peaked at $7.3 million during Q1 2023, and registered a low of $1.2 million during Q1 2022.
  • Moreover, its 2-year median value for Accumulated Expenses was $3.4 million (2023), whereas its average is $3.6 million.
  • Data for Therapeutics' Accumulated Expenses shows a peak YoY surged of 531.87% (in 2023) over the last 5 years.
  • Over the past 2 years, Therapeutics' Accumulated Expenses (Quarterly) stood at $3.8 million in 2022, then rose by 2.09% to $3.4 million in 2023.
  • Its Accumulated Expenses was $3.4 million in Q3 2023, compared to $3.8 million in Q2 2023 and $7.3 million in Q1 2023.